Live Ready-to-Use Models Now Available – No Wait Times!

GenoBioTX is pleased to announce the availability of ready-to-use knockout (KO), knock-in (KI), and overexpression models for preclinical research. With no wait times, researchers can now accelerate their studies using our live genetically engineered models, ensuring efficiency and reliability in critical research areas.

Advancing Preclinical Research Across Key Areas

Our live models are designed to support a wide range of disease applications, including:

Oncology

  • Knockout and knock-in models for tumor research and targeted therapy development

Neurology

  • Overexpression models for neurodegenerative diseases and CNS disorders

Metabolic & Cardiovascular Research

  • KO/KI models for diabetes, obesity, and atherosclerosis

Autoimmune & Infectious Diseases

  • Genetically modified mice for immune system and pathogen response studies

Immediate Availability for Researchers

By eliminating long lead times, these models allow researchers to rapidly initiate their studies without delays, expediting advancements in drug discovery and therapeutic development.

📄 Explore our full list of available live animal models to find the best fit for your research needs.

📩 Contact us today to discuss your project and secure immediate access to these models.

    News Center

    2025.02.25

    The Hidden Killer in Chronic Kidney Disease – Alport Syndrome

    Chronic kidney diseases are highly diverse, but among them, there is a type of chronic kidney disease that may start showing signs in childhood. However, early symptoms are often subtle, leading to neglect by parents or misdiagnosis by doctors, resulting in delayed treatment. Moreover, this disease is hereditary, posing a high risk of developing into […]

    2024.11.01

    CCR8: the Next Promising Immune Checkpoint for Antitumor Drugs Development

    CCR8, as a novel immune checkpoint in tumor microenvironment, was hotly discussed during 2022 AACR conference. Since then, numerous prestigious pharmaceutical corporations have shifted their attention to CCR8, previously almost unknown. You may wonder why CCR8 gave rise to so strong interest of pharmaceutical industry. Just follow us to have a quick review of CCR8, […]

    Email Back to top